Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 98,459,627
- Total 13F shares
- 80,397,353
- Share change
- +10,299,160
- Total reported value
- $3,844,802,509
- Put/Call ratio
- 115%
- Price per share
- $47.82
- Number of holders
- 236
- Value change
- +$498,492,380
- Number of buys
- 133
- Number of sells
- 96
Report period
Q4 2023
Institutions
236
Top holders
10
RARE full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
7,233,168
|
$257,862,440 | — | 30 Sep 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5.5%
|
5,405,089
|
$192,691,423 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.3%
|
5,195,880
|
$185,233,121 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.2%
|
5,079,209
|
$181,073,802 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
3,160,160
|
$112,661,000 | — | 30 Sep 2023 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
2,577,217
|
$91,877,786 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,567,858
|
$91,544,138 | — | 30 Sep 2023 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.3%
|
2,293,570
|
$81,765,784 | — | 30 Sep 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.2%
|
2,196,500
|
$78,305,225 | — | 30 Sep 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
1,943,815
|
$69,297,005 | — | 30 Sep 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.6%
|
1,532,505
|
$54,633,803 | — | 30 Sep 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.5%
|
1,500,000
|
$53,475,000 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.5%
|
1,476,441
|
$52,635,122 | — | 30 Sep 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.4%
|
1,366,547
|
$48,717,401 | — | 30 Sep 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.2%
|
1,201,688
|
$42,840,207 | — | 30 Sep 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.1%
|
1,125,032
|
$40,107,391 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,083,287
|
$38,625,810 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
1%
|
1,027,785
|
$36,640,517 | — | 30 Sep 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.96%
|
947,732
|
$33,786,646 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.96%
|
940,763
|
$33,538,201 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.88%
|
869,388
|
$30,993,682 | — | 30 Sep 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.76%
|
748,278
|
$26,676,111 | — | 30 Sep 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.75%
|
734,272
|
$26,176,797 | — | 30 Sep 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.74%
|
727,426
|
$25,932,737 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.73%
|
716,462
|
$25,541,870 | — | 30 Sep 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
679,459
|
$24,222,713 | — | 30 Sep 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
638,866
|
$22,775,573 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.63%
|
621,706
|
$22,163,809 | — | 30 Sep 2023 | |
| NORGES BANK |
13F
|
Company |
0.61%
|
598,088
|
$21,321,837 | — | 30 Sep 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.55%
|
544,000
|
$19,393,600 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
495,489
|
$17,664,183 | — | 30 Sep 2023 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.5%
|
491,689
|
$17,528,717 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.44%
|
430,672
|
$15,353,457 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
396,725
|
$14,143,246 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
391,303
|
$13,949,935 | — | 30 Sep 2023 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.39%
|
387,323
|
$13,808,065 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.39%
|
385,441
|
$13,740,972 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
374,737
|
$13,359,373 | — | 30 Sep 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
359,000
|
$12,798,350 | — | 30 Sep 2023 | |
| AXA S.A. |
13F
|
Company |
0.35%
|
344,499
|
$12,281,389 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.33%
|
322,571
|
$11,499,657 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.32%
|
310,915
|
$11,084,000 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.28%
|
275,591
|
$9,824,820 | — | 30 Sep 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.26%
|
259,135
|
$9,238,163 | — | 30 Sep 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.25%
|
250,052
|
$8,914,354 | — | 30 Sep 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.25%
|
248,717
|
$8,866,760 | — | 30 Sep 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.24%
|
240,857
|
$8,586,552 | — | 30 Sep 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.23%
|
230,005
|
$8,199,678 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
229,500
|
$8,181,675 | — | 30 Sep 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
221,246
|
$7,887,420 | — | 30 Sep 2023 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q4 2023
As of 31 Dec 2023,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,397,353 shares.
The largest 10 holders included
VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, SANDS CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FEDERATED HERMES, INC., Clearbridge Investments, LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
219
Q4 2023 holders
236
Holder diff
17
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.